Every Form 4 that Procter & Gamble (PG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez received a grant of 273 shares of Common Stock in the form of restricted stock units. The award was made at no cash price as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional units. After this compensation-related grant, his directly held position reported in this filing increased to 36,512.1482 shares of Common Stock, showing this is a relatively small, routine addition to an existing stake rather than a market purchase or sale.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
Procter & Gamble director Craig Arnold received a grant of 161 shares of Common Stock through Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award, which includes dividend equivalents in the form of additional Restricted Stock Units, increased his directly held position to 2,586.0624 shares.
PROCTER & GAMBLE Co executive Francisco Ma. Fatima, CEO of Baby, Fem & Family Care, reported multiple stock moves. On February 27, 2026, she completed open-market sales totaling 5,549 shares of common stock at prices around $165.29 to $165.32, leaving 1,028.739 directly held shares.
She also received a grant of 57.0033 Restricted Stock Units on February 17, 2026, bringing her direct RSU holdings to 888.7607 units. Footnotes explain these RSUs include dividend equivalents that will deliver in shares at retirement or as deferred compensation. Additional indirect common stock holdings are reported through retirement plans, a spouse, and a SLAT trust.
PROCTER & GAMBLE Co executive Susan Street Whaley reported both a stock sale and an equity award. On February 19, 2026, she completed an open-market sale of 1,809 shares of common stock at an average price of $159.4551 per share.
After this sale, her directly held common stock position was 30,215.0293 shares. She also had 6,589.6417 shares held indirectly through a retirement plan trustee. On February 17, 2026, she acquired 11.485 restricted stock units at no cost, increasing her RSU balance to 65.1290 units, which are scheduled to settle in Procter & Gamble common stock, generally in connection with retirement.
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.
On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.
Procter & Gamble’s Chief Human Resources Officer, Purushothaman Balaji, reported an option exercise and share sale on February 11, 2026. He exercised a stock option for 12,827 shares of common stock at an exercise price of $91.07 per share.
On the same day, he sold 12,827 common shares in an open-market transaction at a weighted average price of $160.3093 per share, as disclosed in the footnote. Following these transactions, he held 12,638.8004 shares directly and 5,223.363 shares indirectly through a retirement plan trustee.
Procter & Gamble executive chair Jon R. Moeller, who also serves as a director, reported option exercises and share sales in February 2026. On February 11, he exercised options for 11,036 common shares at $113.23 and sold 11,036 shares at $160. On February 12, he exercised options for 162,232 shares at $113.23 and sold 162,232 shares at a weighted average price of $162.4486. After these transactions, he directly holds 319,384.99 common shares, plus indirect holdings of 25,001.0511 shares through retirement plan trustees and 35,421.5707 shares held by his spouse.
Procter & Gamble CEO – Grooming Gary A. Coombe reported multiple equity transactions in Procter & Gamble common stock. On February 12, 2026, he exercised stock options for 36,093 shares at an exercise price of $78.52 per share, receiving the same number of common shares.
On the same date, he then sold 36,093 common shares in open-market transactions at a weighted average price of $162.3307, leaving 34,993.7893 shares of directly held common stock. He also reports indirect holdings of 486.4342 shares through a retirement plan trustee and 1,295.35 shares through an international stock ownership and pension plan.
In addition, previously granted restricted stock units, including 63.6893 units awarded on November 17, 2025, total 1,117.3663 RSUs. Footnotes explain that these RSUs and some share totals include dividend equivalents and may be delivered in shares upon retirement under the company’s programs.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported a sale of 8,000 shares of common stock on 02/04/2026 at $158 per share. After this sale, she directly holds 6,571.1998 shares of P&G common stock.
She also reports indirect holdings of 16,139.3909 shares through a retirement plan trustee, 2,898.8166 shares held by her spouse and retirement plan trustees, and 12,731 shares held by a SLAT. A footnote states one position reflects an adjustment to PST through December 31, 2025.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported an option exercise and share sale in Procter & Gamble common stock on January 23, 2026. He exercised a stock option for 95,903 shares at an exercise price of $80.29 per share, then sold 95,903 shares of common stock at a weighted average price of $151.1495 per share, within a price range of $150.36 to $151.60. Following these transactions, he directly owned 182,606.5502 shares of Procter & Gamble common stock, with additional indirect holdings through his daughters, retirement plan trustees, and his wife.
Procter & Gamble (PG) director Robert Portman reported a small equity compensation grant. On 12/09/2025, he acquired 54 shares of Procter & Gamble common stock through restricted stock units at a price of $0, reflecting a stock-based award rather than an open-market purchase.
The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in the form of additional restricted stock units. Following this transaction, Portman beneficially owns 4,983.9036 shares of Procter & Gamble common stock in direct ownership.
Procter & Gamble director reports stock award under compensation plan. A company director received an award of 215 shares of Procter & Gamble common stock on 12/09/2025, recorded at a price of $0 per share. The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Following this grant, the director directly beneficially owns 5,562.7456 shares of common stock. This total includes dividend equivalents that were granted in the form of restricted stock units, so it reflects both shares and related stock-based incentives.
Procter & Gamble reported an insider equity award for director Christine M. McCarthy on Form 4. On 12/09/2025, she received 269 shares of Procter & Gamble common stock in the form of Restricted Stock Units, shown at a price of $0 per unit because they are part of her compensation rather than an open-market purchase. These units were granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and her total beneficial ownership after this award is 16,808.9761 shares.
The total ownership figure also includes dividend equivalents that are credited as additional Restricted Stock Units, which means her position can gradually grow as dividends are paid. This filing reflects routine equity compensation for a board member, rather than a large discretionary buy or sale in the market.
Procter & Gamble (PG) reported an insider equity grant to one of its directors. On 12/09/2025, a director acquired 260 shares of common stock in the form of restricted stock units with a stated price of $0, reflecting an award rather than an open-market purchase. The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and the director’s total beneficial ownership after this transaction is 10,978.2065 shares, including dividend equivalents granted as additional restricted stock units.
Procter & Gamble director Joseph Jimenez reported an equity award from the company. On 12/09/2025, he acquired 341 shares of common stock, shown at a price of $0, reflecting a grant of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award, he is shown as beneficially owning 36,083.677 shares of Procter & Gamble common stock in direct ownership. The total includes dividend equivalents granted in the form of additional Restricted Stock Units.
Procter & Gamble Co. reported an equity award to a director under its stock compensation plan. On 12/09/2025, a director of PROCTER & GAMBLE Co (PG) acquired 215 shares of common stock in the form of Restricted Stock Units at a price of $0, reflecting a non-cash grant under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
After this transaction, the director beneficially owned a total of 2,409.2016 shares, including dividend equivalents that were also granted as Restricted Stock Units. The filing is made as a Form 4 by one reporting person in the capacity of director, documenting routine equity-based compensation rather than an open-market purchase or sale.
Procter & Gamble Chairman, President and CEO Jon R. Moeller reported routine updates to his ownership of PG common stock. On 12/03/2025, several transactions occurred, including shares withheld to cover taxes related to previous restricted stock unit (RSU) grants, as noted in the explanations. These withholding transactions reduced his directly held common stock but reflect tax obligations rather than open‑market sales.
The report also shows ongoing activity in RSUs linked to dividend equivalents and the company’s retirement program. Certain RSUs represent a contingent right to receive Procter & Gamble common stock, generally delivering shares upon retirement unless delivery is deferred or contributed to a deferred compensation account. Moeller also reports indirect ownership through retirement plan trustees and holdings attributed to his spouse.
Procter & Gamble’s Chief Legal Officer and Secretary, Susan Street Whaley, reported routine equity compensation activity involving company stock. On 12/03/2025, she acquired 54.39 shares of common stock through the exercise of equity awards and had the same 54.39 shares withheld to cover taxes on a previous restricted stock unit grant, leaving her with 31,902.2845 directly held shares and 6,531.6011 shares held indirectly by a retirement plan trustee.
The filing also shows activity in restricted stock units (RSUs). On 11/17/2025, she received 12.8844 RSUs as dividend equivalents under a retirement program, and certain RSUs will convert into Procter & Gamble common stock upon retirement or may be deferred or settled in cash under the plan’s terms.
Procter & Gamble Chief Financial Officer Andre Schulten reported several equity transactions dated 12/03/2025 related mainly to restricted stock units (RSUs) and tax withholding. The filing shows common shares withheld to cover taxes on a prior RSU grant, including 715.5 shares, 88.63 shares, and 68.49 shares withheld at a price of $144.35 per share. An RSU-related transaction added 88.63 common shares, leaving him with 53,386.4466 common shares held directly and 6,869.3576 shares held indirectly through a retirement plan trustee.
In derivative securities, Schulten received 33.091 RSUs as dividend equivalents tied to Procter & Gamble common stock and a retirement award of 88.63 RSUs, both delivering shares upon or in connection with retirement under the company’s plans. After these transactions, he beneficially owned 218.7078 RSUs from dividend equivalents and 1,171.37 RSUs under the retirement program.
Procter & Gamble executive Sundar G. Raman reported routine equity transactions and awards involving company stock and restricted stock units. On 12/03/2025, he disposed of 59.43 shares of Procter & Gamble common stock at $144.35 per share to cover taxes on previous restricted stock unit grants, and following these transactions held 41,888.5423 shares directly, plus 8,436.9135 shares held indirectly through a retirement plan trustee.
Separately, he recorded activity in restricted stock units. On 11/17/2025, he acquired 31.6587 dividend-equivalent restricted stock units, bringing his direct restricted stock unit holdings in one line to 246.1457 units. On 12/03/2025, he exercised or converted 59.43 restricted stock units, after which another restricted stock unit holding line totaled 995.57 units. Several of these units are tied to Procter & Gamble’s retirement and deferred compensation programs and generally deliver shares upon retirement, subject to plan terms.
Procter & Gamble’s Chief Human Resources Officer, Balaji Purushothaman, reported routine equity transactions in company stock. On 12/03/2025, 38.27 shares of common stock were acquired through the exercise or settlement of derivative securities at a price of $144.35 per share, and the same 38.27 shares were disposed of to cover tax withholding on a prior restricted stock unit grant.
After these transactions, the reporting person directly owned 12,638.8004 shares of common stock and indirectly owned 5,166.0704 shares through a retirement plan trustee. The filing also shows dividend-equivalent restricted stock units, including a 10.5941-unit award on 11/17/2025, and notes that certain units will deliver in shares upon retirement or may be deferred or settled in cash according to plan formulas.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported routine equity transactions involving company stock and restricted stock units. On 12/03/2025, he acquired 94.68 shares of Procter & Gamble common stock through the exercise of derivative securities and had 94.68 shares withheld to cover taxes on a prior restricted stock unit grant at a price of $144.35 per share. After these transactions, he directly owned 182,606.5502 shares of common stock, along with additional indirect holdings through his daughters, a retirement plan, and his spouse.
In a separate transaction dated 11/17/2025, Pritchard received 257.5366 restricted stock units as dividend equivalents, bringing one of his restricted stock unit balances to 9,001.9379 units. Another restricted stock unit entry on 12/03/2025 for 94.68 units is described as a retirement award, leaving a balance of 1,158.32 restricted stock units under that program. These restricted stock units represent contingent rights to receive Procter & Gamble common stock or cash, generally deliverable upon retirement or under the company’s retirement and deferred compensation arrangements.
Procter & Gamble executive Freddy Bharucha, CEO - Beauty, reported equity transactions in company stock. On 12/03/2025, 45.32 shares of common stock were acquired following the vesting of Restricted Stock Units at a reference price of $144.35, coded as an "M" transaction. The same number of shares, 45.32, was then withheld in an "F" transaction to cover taxes on a previous Restricted Stock Unit grant, leaving 1,345.0358 shares of common stock held directly.
In addition, Bharucha holds indirect interests, including 5,051.056 shares through a retirement plan trustee and several indirect positions via a spouse and international plans. The filing also shows 586.68 Restricted Stock Units remaining directly owned, which will deliver in shares upon retirement or as otherwise deferred. These transactions reflect routine equity compensation and tax withholding activity rather than open-market buying or selling.
Procter & Gamble executive Jennifer L. Davis, CEO – Health Care, reported equity transactions in company stock. On 12/03/2025, she acquired 60.43 shares of common stock through an exercise coded “M,” and the same number of shares, 60.43, was withheld in a transaction coded “F” to cover taxes from a prior restricted stock unit grant.
After these transactions, Davis directly owned 61,768.0786 shares of Procter & Gamble common stock and indirectly owned 15,535.3029 shares through a retirement plan trustee. She also reported restricted stock units, including 33.9576 RSUs credited as dividend equivalents and a retirement-related RSU award of 60.43 units, which together left her with 262.6603 and 965.57 RSUs, respectively, subject to delivery terms tied to retirement and the company’s benefit formulas.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported equity transactions in a Form 4. On 12/03/2025, she acquired 73.53 shares of common stock through the exercise of restricted stock units at a price of $144.35 per share, with an equal 73.53 shares withheld to cover taxes on a prior restricted stock unit grant. Following these transactions, she directly owned 14,571.1998 common shares, with additional indirect holdings through retirement plan trustees, her spouse, and a SLAT.
In Table II, she reported restricted stock units, including 62.542 units credited as dividend equivalents on 11/17/2025 and 73.53 units settled on 12/03/2025. These units generally represent contingent rights to receive Procter & Gamble common stock, typically delivering in shares upon retirement under the company’s retirement and deferred compensation programs.
Procter & Gamble officer Aguilar Moses, the company’s Chief Research, Development & Innovation Officer, reported several equity transactions in Procter & Gamble common stock on 12/03/2025. The filing shows multiple tax-withholding transactions (coded “F”) where shares such as 221.09, 55.4, 1,076.71 and 60.43 were withheld at a price of $144.35 per share to cover taxes on restricted stock unit grants. One transaction coded “M” reflects the settlement of 55.4 restricted stock units into common shares.
After these transactions, Moses directly owned 44,735.4826 shares of common stock and also had indirect ownership of 6,808.4349 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan trustee. The filing also reports restricted stock units, including 19.6192 units credited as dividend equivalents on 11/17/2025 and a retirement award, which will generally deliver Procter & Gamble common stock or cash upon retirement under the company’s benefit formulas.
Procter & Gamble senior executive reports small share withholding for taxes. The company’s SVP and Chief Accounting Officer filed a Form 4 after 14.1 shares of Procter & Gamble common stock were withheld on 12/03/2025 to cover taxes on a previous restricted stock unit grant at a price of $144.35 per share. After this tax-related transaction, the executive directly beneficially owns 971.8749 shares of Procter & Gamble common stock and indirectly owns an additional 3,293.5342 shares through a retirement plan trustee. The filing reflects routine equity compensation and tax withholding activity rather than an open-market buy or sell decision.
Procter & Gamble’s Chief Operating Officer and director Shailesh Jejurikar reported equity transactions involving company stock and restricted stock units. On 12/03/2025, he acquired 51.37 shares of common stock through an option or unit exercise at a price of $144.35 per share, then had 51.37 shares and an additional 279 shares withheld to cover taxes on prior restricted stock unit grants at the same price.
After these transactions, he directly owned 28,800.3765 shares of common stock, plus indirect holdings of 3,331.1419 shares through a retirement plan trustee and 19,757 and 35,836 shares through personal trusts. In the derivative table, dividend-equivalent restricted stock units added 42.3852 units on 11/17/2025, and an RSU-related transaction for 51.37 units on 12/03/2025 left him with 673.63 restricted stock units beneficially owned.
Procter & Gamble (PG) reported an insider transaction by its Chief Financial Officer. On 11/10/2025, the reporting person executed a sale (Code S) of 1.2969 shares of common stock at $146.3745 per share. The transaction was held indirectly through a Retirement Plan Trustee. Following this trade, the filer reported 6,869.3576 shares indirect and 53,992.0273 shares direct beneficial ownership.
Procter & Gamble (PG): Form 4 insider transaction
Officer Ma. Fatima Francisco (CEO - Baby, Fem & Family Care) reported a transfer of 12,731 shares of common stock on 11/05/2025, recorded with transaction code G at a price of $0. The filing notes this reflects the transfer of 12,731 shares for no consideration to a spousal lifetime access trust (the “SLAT”).
Following the transaction, holdings reported include 14,564.0856 shares directly, 12,731 indirectly by SLAT, 15,998.3673 indirectly by Retirement Plan Trustee, and 2,862.8125 indirectly by Spouse/Retirement Plan Trustees.
Procter & Gamble (PG) reported an insider transaction on a Form 4. The company’s SVP – Chief Accounting Officer sold 725 shares of Common Stock on 10/30/2025 at $149.57 per share (transaction code S).
Following the sale, the reporting person beneficially owned 978.9031 shares directly and 3,293.5342 shares indirectly by Retirement Plan Trustee. The filing indicates it was submitted by an attorney‑in‑fact.
Procter & Gamble (PG) reported an insider transaction: Director Patricia A. Woertz acquired 31 shares of common stock on 10/14/2025 at $0, coded as an “A” transaction.
The filing notes these were Restricted Stock Units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, Woertz beneficially owns 51,548.5268 shares, held directly.
Procter & Gamble (PG) director Rajesh Subramaniam reported an acquisition of 1,475 shares of common stock on 10/14/2025 via a Form 4. The transaction was coded A (award) at a price of $0, reflecting a grant of Restricted Stock Units under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this award, Subramaniam beneficially owns 6,149.8264 shares directly. The total includes dividend equivalents granted in the form of Restricted Stock Units.
Procter & Gamble (PG) reported a director equity award. On 10/14/2025, Director Robert Portman acquired 1,475 shares of common stock at a price of $0, indicated as restricted stock units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this grant, Portman beneficially owns 4,894.5944 shares, held directly. This filing reflects routine director compensation through equity and does not indicate any open‑market purchase or sale.
Procter & Gamble (PG) director Ashley McEvoy reported an equity award on Form 4. On 10/14/2025, she acquired 1,475 shares of common stock, transaction code “A,” at $0 per footnote, granted under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. After this award, she beneficially owns 5,318.0241 shares, held directly.
Procter & Gamble (PG) director Christine M. McCarthy reported acquiring 1,475 shares of common stock on 10/14/2025 at $0, reflecting Restricted Stock Units awarded under The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Following this transaction, she beneficially owned 16,421.5131 shares, held directly. The filing was made by one reporting person.
Procter & Gamble (PG) director Terry J. Lundgren reported an equity award on a Form 4. On 10/14/2025, he acquired 31 restricted stock units (RSUs) at $0, awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following the transaction, his beneficial ownership stood at 43,428.6912 shares held directly. He also has 530 shares held indirectly through his spouse.
Procter & Gamble (PG): Director equity award reported. On 10/14/2025, a director reported acquiring 1,475 shares of common stock at a price of $0 under transaction code “A” (grant/award). Following the transaction, beneficial ownership stands at 9,270.5578 shares, held directly.
Footnotes state the award was in the form of Restricted Stock Units granted pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan, and that the total includes dividend equivalents credited as additional RSUs.
Procter & Gamble (PG) disclosed an insider equity award. A company director acquired 1,475 shares of Common Stock on 10/14/2025 with a transaction code “A” at $0, reflecting an award under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, the director beneficially owns 10,641.4401 shares, held directly.
Procter & Gamble (PG) director reported acquiring common stock through an equity award. On 10/14/2025, the insider recorded an acquisition of 1,475 shares at $0 per share, identified as an award under the company’s 2019 Stock and Incentive Compensation Plan. Following this transaction, the reporting person beneficially owns 16,961.3928 shares.
The filing notes the grant consisted of Restricted Stock Units and that the total includes dividend equivalents awarded in the form of RSUs.
Procter & Gamble (PG) director Brett M. Biggs reported an equity award. On 10/14/2025, he acquired 1,475 shares of common stock in the form of Restricted Stock Units at $0, granted under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this award, his beneficial ownership stands at 5,306.6502 shares, held directly. The total reflects dividend equivalents credited as additional Restricted Stock Units.
Procter & Gamble (PG) director reported acquiring 1,475 shares of common stock on 10/14/2025, coded “A” for an award. The shares were granted at $0 per the filing’s footnote and reflect a Restricted Stock Unit award under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this transaction, the reporting person beneficially owns 2,178.4862 shares, held directly.
Procter & Gamble (PG) director reported equity award. A Form 4 shows the director acquired 1,475 shares of common stock on 10/14/2025 via Restricted Stock Units at $0, pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, direct beneficial ownership stands at 10,938.442 shares. The total reflects dividend equivalents credited as additional RSUs.
Procter & Gamble (PG) director Joseph Jimenez reported an equity award. On 10/14/2025, he acquired 1,475 shares of common stock at $0, reflecting Restricted Stock Units granted under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, he beneficially owns 35,575.9784 shares, held directly.
Procter & Gamble (PG) reported an insider equity award. Director Sheila Bonini acquired 1,475 shares of common stock on 10/14/2025 at $0, reflecting a grant of Restricted Stock Units (RSUs) under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this grant, Bonini directly holds 4,415.001 shares. The filing notes the total includes dividend equivalents in the form of RSUs.
Insider sale to cover RSU taxes. The Form 4 shows Andre Schulten, Chief Financial Officer of Procter & Gamble (PG), sold 4,252 shares of common stock on 10/02/2025 at $152.2317 per share. The filing states the sale was to cover tax obligations upon settlement of a Restricted Stock Unit award. After the sale, the reporting person beneficially owned 53,992.0273 shares directly and 6,870.6545 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
Procter & Gamble (PG) director and CEO Jon R. Moeller reported a sale of 11,684 shares of Common Stock on 10/02/2025 at a reported price of $152.2317 per share to cover tax obligations from a Restricted Stock Unit award. After the sale, Mr. Moeller's direct beneficial ownership is reported as 319,932.232 shares. He also retains indirect holdings of 24,767.7039 shares through retirement plan trustees and 35,421.5707 shares attributed to his spouse, for combined reported beneficial ownership across direct and indirect holdings.
Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported a sale of 490 shares of common stock on 10/02/2025 at a price of $152.2317 per share to cover tax obligations related to a Restricted Stock Unit settlement. After the sale, the filing shows 12,616.0044 shares owned directly and an additional 5,166.0704 shares held indirectly via a retirement plan trustee, reflecting continued ownership after the transaction. The Form 4 was signed on 10/06/2025 by an attorney-in-fact for the reporting person.
Reporting person: Keith R. Alexandra, listed as an officer (CEO - Beauty). The filing discloses insider sales on 10/02/2025 of a total of 2,254 shares of Procter & Gamble Co (PG) to cover a tax obligation arising from settlement of a Restricted Stock Unit award. The reported sale price for each disposition was $152.2317. After the transactions the reporting person (directly and indirectly) held fractional share totals reported as 25,674.5056 (direct) and indirect interests via spouse and retirement plan trustee totaling additional fractional amounts. The form is signed by an attorney-in-fact on 10/06/2025.
Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported a sale of 3,986 shares of common stock on 10/02/2025 at a price of $152.2317 per share. The filing states the shares were sold to cover tax obligations arising from the settlement of a Restricted Stock Unit award. After the transaction the reporting person shows 46,899.3817 shares directly beneficially owned and additional indirect holdings of 3,331.1419 shares (by a retirement plan trustee), 19,757 shares (Sankhya S Jejurikar Revocable Trust) and 17,849 shares (Shailesh Jejurikar Trust).
The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing is single-person (not a group) and lists the transaction code as S denoting a sale; the explanatory footnote confirms the sale was to cover taxes on RSU settlement.